Bryn Mawr Capital Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.96M Buy
132,025
+344
+0.3% +$24.5K 0.48% 60
2025
Q4
$8.13M Sell
131,681
-1,724
-1% -$101K 0.39% 68
2025
Q3
$7.83M Buy
133,405
+9,450
+8% +$551K 0.39% 70
2025
Q2
$7.22M Buy
123,955
+33,220
+37% +$1.88M 0.4% 69
2025
Q1
$4.51M Buy
90,735
+6,389
+8% +$327K 0.27% 87
2024
Q4
$3.77M Buy
84,346
+7,286
+9% +$346K 0.2% 106
2024
Q3
$3.7M Sell
77,060
-14,311
-16% -$690K 0.2% 111
2024
Q2
$4.65M Buy
+91,371
New +$5M 0.26% 90

Other funds holding NTR

Bryn Mawr Capital Management's NTR Position: Q1 2026 in Review

Bryn Mawr Capital Management increased its Nutrien (NTR) stake by 0.26% in Q1 2026, buying an estimated $24.5K and bringing the position to 132,025 shares worth $9.96M. The position accounts for 0.48% of the portfolio, ranked #60.

Bryn Mawr Capital Management first reported a position in NTR in Q2 2024 and has held it in 8 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Bryn Mawr Capital Management held 132,025 shares of Nutrien worth $9.96M as of Q1 2026.
  • Bryn Mawr Capital Management bought 344 Nutrien shares in Q1 2026, an estimated $24.5K.
  • Nutrien made up 0.48% of Bryn Mawr Capital Management's portfolio in Q1 2026, its #60 holding.
  • Bryn Mawr Capital Management first reported a position in Nutrien in Q2 2024 and has held it in 8 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q1 2026, filed 4 May 2026.